Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 487.00
+14.00 (2.96%)
Sep 30, 2026, 4:08 PM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 116.4 billion as of October 1, 2026. Its market cap has increased by 0.72% in one year.
Market Cap
116.40B
Enterprise Value
110.98B
Revenue
2.41B
Ranking
n/a
PE Ratio
666.81
Stock Price
487.00
ChartMarket Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 116.40B, an increase of 762.94%. That is a compound annual growth rate of 95.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 116.40B | 27.28% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 321.84B |
| WuXi Biologics | 219.14B |
| Innovent Biologics | 167.39B |
| Sino Biopharmaceutical | 97.84B |
| Genscript Biotech | 95.78B |
| Akeso | 84.75B |
| RemeGen | 62.49B |
| Biocytogen Pharmaceuticals (Beijing) | 57.42B |